Cita APA

Hoogendijk, A. J., Wiewel, M. A., van Vught, L. A., Scicluna, B. P., Belkasim-Bohoudi, H., Horn, J., . . . van der Poll, T. (2015). Plasma fractalkine is a sustained marker of disease severity and outcome in sepsis patients. Crit Care.

Chicago Style Citation

Hoogendijk, Arie J., et al. "Plasma Fractalkine Is a Sustained Marker of Disease Severity and Outcome in Sepsis Patients." Crit Care 2015.

Cita MLA

Hoogendijk, Arie J., et al. "Plasma Fractalkine Is a Sustained Marker of Disease Severity and Outcome in Sepsis Patients." Crit Care 2015.